News

January 2025

Sanders TDI Collaboration Sheds Light on How Tertiary Lymphoid Structures Form

December 2024

Sanders TDI Participates in Discovery of New Anti-viral

December 2024

Sanders TDI's First Graduated Molecule Completes Phase 1

October 2024

Galecto Acquires AML Asset from Bridge Medicines, Inc.

February 2024

Tigen Pharma Options MSK CAR T-cell therapy

November 2023

Sanders Tri-Institutional Therapeutics Discovery Institute, Inc. Celebrates New Name and 10 Years of Growth and Innovation

September 2023

NIH Center Grant Bolsters Male Contraceptive Research

February 2023

TDI's First Project Reaches Phase I Clinical Studies

February 2023

On-Demand Male Contraceptive Shows Promise in Preclinical Study

May 2022

Academia, Pharma Team up to Discover New Drugs in Fight Against SARS-CoV-2, Viruses of the Future

November 2020

Caribou Biosciences Licenses fully human anti-CD371 scFvs

March 2022

TDI collaboration leads to anti-ART1 antibody: A potential immune-enhancing cancer treatment

January 2022

Tri-I TDI Relocating to New RU Translational Center

January 2021

Dr Dan Heller Wins TDI Central Protein Database Prize

July 2020

Dr Sara Parsa Wins TDI Central Protein Database Prize

April 2020

TDI Launches Central Protein Database